Execution remains solid and I prefer to see BCT continue announcing real commercial contracts and partnerships as they have instead of just trying to bring noise into the stock with anns like free sample trialing which is just rubbish and the norm in micro cap land.
In fact even if a customer wants to trial their technology, they have to pay for it. That shows the robustness of the business model and technology.
Let the CR punters sell and lucky those with spare cash to grab more at these levels.
- Forums
- ASX - By Stock
- BCT
- IM interview
IM interview, page-6
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.737M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BCT (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online